By Linda Chiem ( February 5, 2014, 11:55 AM EST) -- Myriad Genetics Inc. announced Tuesday that it will acquire venture capital-backed Crescendo Bioscience Inc., a South San Francisco-based manufacturer of tests for inflammatory and autoimmune diseases such as rheumatoid arthritis, for $270 million in cash....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.